GOLD vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The company presents a classic 'growth trap' profile, with a stable Piotroski F-Score of 4/9 but severe valuation misalignment. The current price of $47.21 trades at a massive premium to both the Graham Number ($16.84) and the Intrinsic Value ($14.16). While revenue growth is explosive at 136.20%, the business operates on razor-thin profit margins (0.08%) and maintains an unsustainable dividend payout ratio of 166.67%. Combined with heavy insider selling and a consistent track record of missing earnings estimates, the current valuation is fundamentally unsupported.
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Compare Another Pair
Related Comparisons
GOLD vs JPM: Head-to-Head Comparison
This page compares Gold.com, Inc. (GOLD) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.